Substrate
technology

Cerebras Systems Closes First Day of Nasdaq Trading With $95 Billion Market Value

Cerebras Systems ended its first day of trading on Wall Street with a market capitalization just below $100 billion after a blockbuster IPO. The AI chipmaker's shares popped 68 percent in its Nasdaq debut before trading lower on Friday. Co-founders Andrew Feldman and Sean Lie became billionaires from the offering.

cnbc.com
1 source·May 15, 3:11 PM·2m read
Cerebras Systems Closes First Day of Nasdaq Trading With $95 Billion Market Valuecnbc.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

Cerebras Systems closed its first day of trading on Wall Street with a market cap just below $100 billion. The AI chipmaker popped 68 percent in its Nasdaq debut, pushing its market capitalization to $95 billion and placing it near the few companies to close above that mark, such as Facebook-parent Meta and Alibaba. Its monster debut on Thursday did not just rank among tech's biggest-ever IPOs.

The stock traded lower on Friday, its first full day of trading. Cerebras makes a chip the size of a dinner plate. "We build the biggest chips in the semiconductor industry," Andrew Feldman said. "Big chips process more information in less time and deliver results more quickly," Feldman added.

Cerebras' WSE-3 is 57 times larger than the largest GPU and has 50 times the number of transistors as the largest GPU. The most advanced AI chips are made using Taiwan Semiconductor Manufacturing's 2-nanometer process node, while Cerebras' chip is made at TSMC on its 5-nanometer node. Cerebras was founded in Silicon Valley in 2016.

It first filed to go public in 2024 but withdrew its 2024 IPO submission when it faced scrutiny for its heavy reliance on a single customer, Microsoft-backed AI firm G42 in the United Arab Emirates. With the firm's successful IPO on Thursday, Feldman and hardware technology chief Sean Lie, two of its co-founders, became billionaires based on their holdings.

Cerebras and OpenAI announced a $20 billion cloud deal in January that expires in 2028.

Amazon Web Services announced in March that it's using Cerebras chips in its data centers. "For our fast inference product, there's so much demand that our biggest challenge is actually trying to supply it. We are adding as much manufacturing and data center capacity as we possibly can, and we're still sold out into 2027," Cerebras CFO Bob Komin said.

Nvidia paid $20 billion for Groq's tech in December. Nvidia announced custom Groq Language Processing Units at GTC in March. Intel participated in a $350 million funding round for SambaNova in February, and Intel CEO Lip-Bu Tan has served as SambaNova's chairman since 2017.

34 billion, in March. Rebellions is preparing for an IPO. com reported.

The company now largely operates its chips inside its own data centers as a cloud service. It competes with cloud providers including Google, Microsoft, Oracle and CoreWeave. Cerebras' debut signals strong investor appetite for alternatives to Nvidia's GPUs as demand for inference-focused chips grows.

Transparency

1 source · single source
CorroborationLimited · 1 source

Story details

Related Stories

Frontier AI Labs Report Rapid Capability Gains and AI-Written Code; Anthropic Calls for Coordinated SlowdownBusiness Insider
ai37 min agoUpdated

Frontier AI Labs Report Rapid Capability Gains and AI-Written Code; Anthropic Calls for Coordinated Slowdown

Anthropic called for a slowdown or pause among labs developing the most advanced AI systems. The request appeared in a Thursday blog post from its research institute.

Business Insider
Semafor
nypost.com
DA
4 sources
Bumblebees Demonstrate Spontaneous Object Manipulation in Controlled ExperimentsArs Technica
technology37 min agoUpdated

Bumblebees Demonstrate Spontaneous Object Manipulation in Controlled Experiments

A study published in Science shows bumblebees can spontaneously use a ball as a ladder to reach a flower, marking the first demonstration of this type of problem-solving in an insect.

Ars Technica
Science News
uctoday.com
timesofindia.indiatimes.com
4 sources
Small Phase 1 Safety Trial Tests First AI-Designed Coronavirus Vaccine CandidateEuronews
ai2 hrs ago

Small Phase 1 Safety Trial Tests First AI-Designed Coronavirus Vaccine Candidate

A Phase 1 safety study of an AI-designed protein vaccine against multiple coronaviruses enrolled 39 volunteers and reported no significant safety issues. A Phase 2 trial is now planned.

Euronews
SK
BBC News
3 sources